Portfolio Products by trade name   Back
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
NOMIGREN, film-coated tablets, 200 mg + 80 mg + 25 mg + ...
NOMIGREN
International nonproprietary name : propyphenazone + caffeine + camylofin + mecloxamine + ergotamine Product category : Prescription medicines (Rx) Strength : 200 mg + 80 mg + 25 mg + 20 mg + 0.75 mg Pharmaceutical form : film-coated tablets Packaging : 10 film-coated tablets Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N02
ANALGESICS
N02C
ANTIMIGRAINE PREPARATIONS
N02CA
Ergot alkaloids
N02CA52
Ergotamine, combinations excl. psycholeptics
NOMIGREN, film-coated tablets, 200 mg + 80 mg + 25 mg + ...
NOMIGREN
International nonproprietary name : propyphenazone + caffeine + camylofin + mecloxamine + ergotamine Product category : Prescription medicines (Rx) Strength : 200 mg + 80 mg + 25 mg + 20 mg + 0.75 mg Pharmaceutical form : film-coated tablets Packaging : 20 film-coated tablets Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N02
ANALGESICS
N02C
ANTIMIGRAINE PREPARATIONS
N02CA
Ergot alkaloids
N02CA52
Ergotamine, combinations excl. psycholeptics
NOMIGREN, film-coated tablets,
NOMIGREN
International nonproprietary name : Product category : Prescription medicines (Rx) Strength : Pharmaceutical form : film-coated tablets Packaging : phial with 10 film-coated tablets Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N02
ANALGESICS
N02C
ANTIMIGRAINE PREPARATIONS
N02CA
Ergot alkaloids
N02CA52
Ergotamine, combinations excl. psycholeptics
NOMIGREN, film-coated tablets,
NOMIGREN
International nonproprietary name : Product category : Prescription medicines (Rx) Strength : Pharmaceutical form : film-coated tablets Packaging : phial with 20 film-coated tablets Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N02
ANALGESICS
N02C
ANTIMIGRAINE PREPARATIONS
N02CA
Ergot alkaloids
N02CA52
Ergotamine, combinations excl. psycholeptics
Q&A
If you have a question about any of our products, check whether it has already been answered in the Questions and Answers section.
TAKE A LOOK AT Q&A
If you are unable to find the answer under Q&A, then send your question and one of our medical or pharmaceutical experts will answer.

prijava-icon
Newsletter
If you are a medical doctor or pharmacist, why not subscribe to our mailing list and receive the latest updates.
SUBSCRIBE
I hereby confirm that I am a medical professional*
I want to receive information and newsletters from Bosnalijek*
april 26. 2024 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%